Track topics on Twitter Track topics that are important to you
This is the first evidence of a survival benefit with a chemotherapy-free targeted therapy regimen in BRAF V600E-mutant colorectal cancer, say reserachers.
Medscape Medical News
Original Article: BEACON Lights Way for Chemo-Free Therapy in Colorectal CancerNEXT ARTICLE
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...